°í°­µµ ¿ÍÆĸ° Åõ¾à ÈÄ ³­Ä¡µÎÅëÀÌ È£ÀüµÈ Ç×ÀÎÁöÁúÇ×üÁõÈıº 1¿¹
A Case of Refractory Headache with Antiphospholipid Antibody Syndrome Improved by High-Intensity Warfarin Medication

´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö 2014³â 21±Ç 2È£ p.74 ~ p.76

Á¶°æÈñ(Cho Kyung-Hee) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
¾çÁرÔ(Yang Jun-Gyu) - °è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
±èÁö¼±(Kim Ji-Sun) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
À̼º¿í(Lee Sung-Woog) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç

Abstract

Antiphospholipid antibody syndrome (APS) is a coagu-lation disorder associated with antiphospholipid antibodies. Headache is common in APS patients and often un-responsive to analgesics. We report a case of refractory headache in a patient with APS, who was improved by high-intensity warfarin treatment. The mechanisms of the headache in patients with APS were presumed to be hyper-coagulability of microcirculation and thrombotic occlusion of the capillaries, which were associated with anti-phospholipid antibodies. Therefore, high-intensity warfarin could be considered as one of the treatments for refractory headache in patients with APS.

Å°¿öµå

Antiphospholipid antibody syndrome, Headache, Warfarin
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå